Method of applying acoustic energy effective to alter transport or cell viability

• US 7,972,286 B2
• Filed: 11/02/2006
• Issued: 07/05/2011
• Est. Priority Date: 01/12/1998
• Status: Expired due to Fees

• Current Assignee: Georgia Tech Research Corporation (University System of Georgia)
• Original Assignee: Georgia Tech Research Corporation (University System of Georgia)
• Inventors: Liu, Jin, Lewis, Thomas N., Prausnitz, Mark R.
• Primary Examiner(s): Smith; Ruth S
• Application Number:
  US11/556,074
• Publication Number:
  US 20070073197A1
• Time in Patent Office: 1,706 Days
• Field of Search: 601/2, 601/3, 604/22, 604/290, 604/500, 600/309, 600/439
• US Class Current: 601/2
• CPC Class Codes: A61B 5/14532 for measuring glucose, e.g. by tissue impedance measurement
• CPC Class Codes: A61K 41/0023 Agression treatment or altering
• CPC Class Codes: A61K 41/0047 Sonopheresis, i.e. ultrasonically-enhanced transdermal delivery, electroporation of a pharmacologically active agent
• CPC Class Codes: A61M 37/0092 using ultrasonic, sonic or infrasonic vibrations, e.g. phonophoresis

Abstract

A method for reversibly, or irreversibly, altering the permeability of cells, tissues or other biological barriers, to molecules to be transported into or through these materials, through the application of acoustic energy, is provided. The acoustic energy is applied indirectly to the cells or tissue whose permeability is to be altered, at a frequency and intensity appropriate to alter the permeability to achieve the desired effect, such as the transport of endogenous or exogenous molecules and/or fluid, for drug delivery, measurement of analyte, removal of fluid, alteration of cell or tissue viability or alteration of structure of materials. In the preferred embodiment, the method includes applying the ultrasound in combination with devices for monitoring and/or implementing feedback controls.

Claims

1. A method for altering permeability of tissues or cells comprising

(a) administering acoustic energy at a driving frequency by applying a transducer to a first site on a human or other animal,

wherein the first site is selected from the group consisting of skin, cornea, conjunctiva, sclera, mucosa of the nose, mucosa of the mouth, mucosa of the rectum and mucosa of the vagina,

wherein the acoustic energy is effective to increase permeability of tissues or cells at a second site distant from the first site, wherein the second site is not skin, cornea, conjunctiva, sclera, mucosa of the nose, mucosa of the mouth, mucosa of the rectum or mucosa of the vagina, and

wherein the acoustic energy does not alter permeability, cell viability or structural integrity at the first site,

(b) measuring the effect on the second site of the acoustic energy or a property of the acoustic energy at the time of or subsequent to the initial application of the acoustic energy,

wherein the effect on the second site or the property of the acoustic energy is measured at (i) one or more frequencies other than the driving frequency at which the acoustic energy is applied, wherein the one or more frequencies correspond to integer multiples of one-half or one-fourth of the driving frequency, or

(ii) one or more frequencies taken from a broadband signal at a frequency greater than the driving frequency, and

(c) using the measurement obtained in step (b) to modify continued or subsequent application of acoustic energy from the transducer at the first site.

2. The method of claim 1 wherein the property of the acoustic energy being measured in step b is one or more properties selected from the group consisting of pressure, energy input, and length of time the acoustic energy is administered.

3. The method of claim 1 wherein the increased permeability is partially or completely reversible.

4. The method of claim 1 wherein the second site is a biological membrane.

5. The method of claim 1 wherein the acoustic energy is applied in an amount effective to disaggregate or dissociate cells or tissue in the second site.

6. The method of claim 1 wherein the second site comprises blood vessels.

7. The method of claim 1 wherein the acoustic energy is applied at a frequency between 1 kHz and 10 MHz.

8. The method of claim 1 wherein the acoustic energy is ultrasound.

9. The method of claim 1 wherein the acoustic energy is applied at a peak positive pressure of up to 100 atmospheres.

10. The method of claim 1 wherein the application of acoustic energy causes cavitation within or on the surface of the second site.

11. The method of claim 1 further comprising administering an agent to the second site to alter permeability of the second site.

12. The method of claim 1 wherein the property of the acoustic energy is measured at a frequency or frequencies corresponding to integer multiples of one-half or one-fourth of the driving frequency.

13. The method of claim 1 wherein the acoustic energy measurement is analyzed using a mathematical algorithm selected from the group consisting of Fourier Transform and the Fast Fourier Transform.

14. The method of claim 1 wherein the application of the acoustic energy is modified by changing an acoustic parameter selected from the group consisting of pressure, energy, frequency, pulse length, total exposure time, duty cycle, and combinations thereof.

15. The method of claim 1 wherein the application of the acoustic energy is modified by changing a non-acoustic parameter selected from the group consisting of temperature, fluid gas content, administration rate of molecules to be transported, sample collection rate, device position, and combinations thereof.

16. The method of claim 1 wherein the application of the acoustic energy is modified by interrupting the application.

17. The method of claim 1 wherein the second site comprises a tumor.

18. The method of claim 1 wherein the acoustic energy alters transport of molecules selected from the group consisting of therapeutic, prophylactic and diagnostic agents.

19. The method of claim 1, wherein the second site is selected from the group consisting of the gastrointestinal tract, pulmonary mucosa, blood and lymphatic vessel walls, internal organs, tumors, and bones.

20. The method of claim 1 wherein the acoustic energy is effective to increase permeability of the second site to a chemical or biological agent selected from the group consisting of peptides, proteins, sugars, polysaccharides, nucleotides, polynucleotide molecules, synthetic organic compounds, synthetic inorganic compounds, and combinations and aggregates thereof.

21. The method of claim 20 wherein the chemical or biological agent is delivered to cells or tissue at the second site.

22. The method of claim 21 wherein the chemical or biological agent is in a form selected from the group consisting of cells or virus particles, nano or microparticles, liposomes or other lipid vesicles or emulsions.

23. The method of claim 21 wherein the chemical or biological agent is detected or quantitated, further comprising

removing biological fluid or molecules simultaneously, previously, or subsequently to the application of acoustic energy, and

assaying the biological fluid or molecules to detect or quantitate the chemical or biological agent.

24. The method of claim 1 wherein the property of the acoustic energy is measured at one or more frequencies taken from the broadband signal at frequencies greater than the driving frequency.